6,441
Views
12
CrossRef citations to date
0
Altmetric
Coronavirus – Research Paper

Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale

ORCID Icon, , &
Pages 1-10 | Received 24 Aug 2021, Accepted 13 Nov 2021, Published online: 17 Dec 2021

References

  • Haleem A, Javaid M, Vaishya R. Effects of COVID 19 pandemic in daily life. Curr Med Res Pract. 2020;10(2):78. doi:10.1016/j.cmrp.2020.03.011.
  • Alola AA, Olowu FB. The health scare of COVID-19 amidst pandemics and the immune-related pharmaceutical products spillovers in the USA. Environ Sci Pollut Res. 2020;27(36):45949–56. doi:10.1007/s11356-020-11195-z.
  • Alola AA, Alola UV, and Sarkodie SA. The nCOVID-19 and financial stress in the USA: health is wealth. Environ Dev Sustainability. 2020;23:9367–78. doi: 10.1007/s10668-020-01029-w.
  • Bhopal S, Nielsen M. Vaccine hesitancy in low- and middle-income countries: potential implications for the COVID-19 response. Arch Dis Child. 2020;106(2):113–14. doi:10.1136/archdischild-2020-318988.
  • Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;16:1–10. doi:10.1038/s41591-021-01454-y.
  • Truong J, Bakshi S, Wasim A, Ahmad M, and Majid U. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis. Health Promot Int. 2021;105:1–13. doi:10.1093/heapro/daab105.
  • Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy. Hum Vaccines Immunother. 2013;9(8):1763–73. doi:10.4161/hv.24657.
  • MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
  • Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, Schuster M, MacDonald NE, Wilson R. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015;33(34):4165–75. doi:10.1016/j.vaccine.2015.04.037.
  • Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, Jenner L, Petit A, Lewandowsky S, Vanderslott S, et al. COVID-19 vaccine hesitancy in the UK: the Oxford Coronavirus explanations, attitudes, and narratives survey (OCEANS) II. Psychol Med. 2020;11:1–34. doi:10.1017/S0033291720005188.
  • Determann D, de Bekker-grob EW, French J, Voeten HA, Richardus JH, Das E, Korfage IJ. Future pandemics and vaccination: public opinion and attitudes across three European countries. Vaccine. 2016;34(6):803–08. doi:10.1016/j.vaccine.2015.12.035.
  • Myers LB, Goodwin R. Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health. 2011;11(1). doi:10.1186/1471-2458-11-15.
  • Robertson E, Reeve KS, Niedzwiedz CL, Moore J, Blake M, Green M, Katikireddi SV, Benzeval MJ. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study. Brain. 2021;94:41. doi:10.1101/2020.12.27.20248899.
  • Forman R, Shah S, Jeurissen P, Jit M, Mossialos E. COVID-19 vaccine challenges: what have we learned so far and what remains to be done? Health Policy (New York). 2021;125(5):553–67. doi:10.1016/j.healthpol.2021.03.013.
  • Freeman D, Lambe S, Yu L-M, Freeman J, Chadwick A, Vaccari C, Waite F, Rosebrock L, Petit A, Vanderslott S, et al. Injection fears and COVID-19 vaccine hesitancy. Psychol Med. 2021;1–11. doi:10.1017/S0033291721002609.
  • Rief W. Fear of adverse effects and COVID-19 vaccine hesitancy: recommendations of the treatment expectation expert group. JAMA Health Forum. 2021;2(4):e210804. doi:10.1001/jamahealthforum.2021.0804.
  • Karlsson LC, Soveri A, Lewandowsky S, Karlsson L, Karlsson H, Nolvi S, Karukivi M, Lindfelt M, Antfolk J. Fearing the disease or the vaccine: the case of COVID-19. Pers Individ Dif. 2021;172(1):110590. doi:10.1016/j.paid.2020.110590.
  • Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccines Immunother. 2019;15(7–8):1615–27. doi:10.1080/21645515.2018.1564436.
  • Shapiro GK, Tatar O, Dube E, Amsel R, Knauper B, Naz A, Perez S, Rosberger Z. The vaccine hesitancy scale: psychometric properties and validation. Vaccine. 2018;36(5):660–67. doi:10.1016/j.vaccine.2017.12.043.
  • Rodriguez VJ, Alcaide ML, Salazar AS, Montgomerie EK, Maddalon MJ, and Jones DL. Psychometric properties of a vaccine hesitancy scale adapted for COVID-19 vaccination among people with HIV. AIDS Behav. 2021;1–6. doi: 10.1007/s10461-021-03350-5.
  • Jennings W, Stoker G, Bunting H, Valgarðsson VO, Gaskell J, Devine D, McKay L, Mills MC. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines. 2021;9(6):593. doi:10.3390/vaccines9060593.
  • Chadwick A, Kaiser J, Vaccari C, Freeman D, Lambe S, Loe BS, Vanderslott S, Lewandowsky S, Conroy M, Ross ARN, et al. Online social endorsement and Covid-19 vaccine hesitancy in the United Kingdom. Social Media. 2021;7(2):205630512110088. doi:10.1177/20563051211008817.
  • Baumeister RF, Bratslavsky E, Finkenauer C, Vohs KD. Bad is stronger than good. Rev Gen Psychol. 2001;5(4):323–70. doi:10.1037/1089-2680.5.4.323.
  • Marschalko EE, Kotta I, Kalcza-Janosi K, Szabo K, Psychological J-FS. Predictors of COVID-19 prevention behavior in Hungarian women across different generations. Front Psychol. 2021;12:10. doi:10.3389/fpsyg.2021.596543.
  • LaCour M, Davis T. Vaccine skepticism reflects basic cognitive differences in mortality-related event frequency estimation. Vaccine. 2020;38(21):3790–99. doi:10.1016/j.vaccine.2020.02.052.
  • Bendau A, Plag J, Petzold MB, Ströhle A. COVID-19 vaccine hesitancy and related fears and anxiety. Int Immunopharmacol. 2021;97:107724. doi:10.1016/j.intimp.2021.107724.
  • Luo F, Ghanei Gheshlagh R, Dalvand S, Saedmoucheshi S, Li Q. Systematic review and meta-analysis of fear of COVID-19. Front Psychol. 2021:12:1311. doi:10.3389/fpsyg.2021.661078.
  • Mathews A, Mackintosh B, Fulcher EP. Cognitive biases in anxiety and attention to threat. Trends Cogn Sci. 1997;1(9):340–45. doi:10.1016/s1364-6613(97)01092-9.
  • Europe: COVID-19 vaccination rate by country 2021. Statista. [accessed 2021 Nov 20]https://www.statista.com/statistics/1196071/covid-19-vaccination-rate-in-europe-by-country/
  • Williams B, Onsman A, and Brown T. Exploratory factor analysis: a five-step guide for novices. Australasian J Paramed. 2010;8(3):1–13. doi:10.33151/ajp.8.3.93.
  • Ahorsu DK, Lin C-Y, Imani V, Saffari M, Griffiths MD, and Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict. 2020; 1–9. doi: 10.1007/s11469-020-00270-8.
  • Jankovic S, Antonijevic G, Mirkovic S, Raspopovic K, Radoicic L, Putnik S, Zivkovic-Radojevic M, Vasic I, Nikolic B, Stanojevic D, et al. Surgical Fear Questionnaire (SFQ) - Serbian cultural adaptation. Vojnosanitetski Pregled. 2020;77(12):1266–70. doi:10.2298/vsp180410002j.
  • Maridor M, Ruch S, Bangerter A, Emery V. Skepticism toward emerging infectious diseases and influenza vaccination intentions in nurses. J Health Commun. 2017;22(5):386–94. doi:10.1080/10810730.2017.1296509.
  • Field A. Discovering statistics using SPSS: (and sex and drugs and rock “n” roll). London: Sage, Cop; 2009.
  • Bentler PM, Bonett DG. Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull. 1980;88(3):588–606. doi:10.1037/0033-2909.88.3.588.
  • Vandenberg RJ. Introduction: statistical and methodological myths and urban legends. Org Res Methods. 2006;9(2):194–201. doi:10.1177/1094428105285506.
  • Tabachnick BG, and Fidell LS. Using multivariate statistics. 5th ed. Boston: Cop.: Pearson Education/Allyn & Bacon; 2007.
  • Hooper D, Coughlan J, Mullen M. Structural equation modelling: guidelines for determining model fit. Electronic J Bus Res Methods. 2008;6:53–60.
  • HuL, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model. 1999;6(1):1–55. doi:10.1080/10705519909540118.
  • Browne M, Cudeck R. Single sample cross-validation indices for Covariance structures. Multivariate Behav Res. 1989;24(4):445–55. doi:10.1207/s15327906mbr2404_4.
  • Marsh HW, and Grayson D. Latent variable models of multitrait-multimethod data. In: Structural equation modeling. Concepts, issues, and applications ed. Hoyle, RH. Thousand Oaks (CA): Sage; 1995. p. 177–98.
  • Schermelleh-Engel K, Moosbrugger H, Müller H. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. Methods Psychol Res. 2003;8:23–74.
  • Bollen KA, New Incremental A. Fit index for general structural equation models. Sociol Methods Res. 1989;17(3):303–16. doi:10.1177/0049124189017003004.
  • Mulaik SA, James LR, Van Alstine J, Bennett N, Lind S, Stilwell CD. Evaluation of goodness-of-fit indices for structural equation models. Psychol Bull. 1989;105(3):430–45. doi:10.1037/0033-2909.105.3.430.